Accessibility Menu
Organigram Global logo

Organigram Global

(NASDAQ) OGI

Current Price$1.07
Market Cap$144.52M
Since IPO (2014)-87%
5 Year-91%
1 Year-20%
1 Month-24%

Organigram Global Financials at a Glance

Market Cap

$144.52M

Revenue (TTM)

CA$274.13M

Net Income (TTM)

-CA$25.23M

EPS (TTM)

-$0.14

P/E Ratio

-7.66

Dividend

$0.00

Beta (Volatility)

1.53 (High)

Price

$1.07

Volume

6,831

Open

$1.10

Previous Close

$1.07

Daily Range

$1.07 - $1.10

52-Week Range

$1.04 - $2.24

OGI: Motley Fool Moneyball Superscore

41

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Organigram Global

Industry

Pharmaceuticals

Employees

1,139

CEO

James Hideo Yamanaka, MBA

Headquarters

Moncton, NB E1E 3X3, CA

OGI Financials

Key Financial Metrics (TTM)

Gross Margin

-3%

Operating Margin

-39%

Net Income Margin

-9%

Return on Equity

-7%

Return on Capital

-24%

Return on Assets

-5%

Earnings Yield

-13.05%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$144.52M

Shares Outstanding

136.34M

Volume

6.83K

Avg. Volume

687.68K

Financials (TTM)

Gross Profit

CA$6.83M

Operating Income

-CA$63.41M

EBITDA

-CA$14.76M

Operating Cash Flow

-CA$4.30M

Capital Expenditure

-CA$12.22M

Free Cash Flow

-CA$16.52M

Cash & ST Invst.

CA$29.03M

Total Debt

CA$8.75M

Organigram Global Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$59.79M

-8.9%

Gross Profit

CA$16.41M

-10.9%

Gross Margin

27.44%

N/A

Market Cap

$144.52M

N/A

Market Cap/Employee

$132.22K

N/A

Employees

1,093

N/A

Net Income

-CA$921.00K

-102.2%

EBITDA

-CA$4.76M

-73.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

CA$46.68M

+933.3%

Accounts Receivable

CA$53.53M

+14.3%

Inventory

CA$135.51M

+17.8%

Long Term Debt

CA$7.26M

-11.8%

Short Term Debt

CA$959.47K

-26.5%

Return on Assets

-4.84%

N/A

Return on Invested Capital

-24.48%

N/A

Free Cash Flow

-CA$6.54M

+71.7%

Operating Cash Flow

-CA$6.32M

+61.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DERMJourney Medical Corporation
$6.06+0.66%
RNACCartesian Therapeutics, Inc.
$6.27-2.26%
ACBAurora Cannabis Inc.
$3.42-2.56%
HSDTSolana Company
$1.48-7.50%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$214.60-0.04%
INTCIntel
$112.56+0.04%
MRVLMarvell Technology
$301.60+0.04%
IBITiShares Bitcoin Trust
$37.01-0.03%

Questions About OGI

What is the current price of Organigram Global?

Organigram Global is trading at $1.07 per share.

What is the 52-week range for Organigram Global?

Over the past 52 weeks, Organigram Global has traded between $1.04 and $2.24.

How much debt does Organigram Global have?

As of the most recent reporting period, Organigram Global reported total debt of CA$5.87M.

How much cash does Organigram Global have on hand?

Organigram Global reported CA$38.65M in cash and cash equivalents in its most recent financial results.

What is Organigram Global’s dividend yield?

Organigram Global does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.